AUSTEDO ® global revenues of $2.26 billion, growing 34% YoY in LC. Increased by 2% in the U.S., decreased by 2% in Europe and decreased by 2% in International Markets, all in LC terms compared to 2024 ...
The two updates underscore Teva’s strong execution of its Pivot to Growth strategy and commitment to financial discipline. Moody's affirmed Teva's B1a rating and revised Teva's outlook to positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results